| |
| |
|
| Insider
Information: |
Buchalter Jeffrey H |
| Relationship: |
CEO & President, Direc... |
| City: |
San Antonio |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
529,259 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$39,694 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
529,259 |
|
|
| Total
Value |
$39,694 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enzon Pharmaceuticals Inc |
ENZN |
CEO & President, Direc... |
2010-01-27 |
529,259 |
2004-09-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENZN |
Enzon Pharmaceuticals In... |
CEO & President |
• • – |
2010-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
37,994 |
529,259 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
CEO & President |
• • – |
2010-01-17 |
4 |
D |
$10.91 |
$429,756 |
D/D |
(39,391) |
491,265 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
CEO & President |
• • – |
2010-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
99,999 |
530,656 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
CEO & President |
• • – |
2009-12-22 |
4 |
D |
$10.77 |
$114,539 |
D/D |
(10,635) |
530,656 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
CEO & President |
• • – |
2009-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
541,291 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman, CEO & President |
• • – |
2009-11-23 |
4 |
D |
$10.37 |
$169,674 |
D/D |
(16,362) |
541,291 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman, CEO & President |
• • – |
2009-11-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,000 |
557,653 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman of the Board & CEO |
• • – |
2009-04-03 |
4 |
D |
$6.12 |
$165,307 |
D/D |
(27,011) |
521,653 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman of the Board & CEO |
• • – |
2009-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,430 |
548,664 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman, CEO & President |
• • – |
2008-11-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,000 |
489,234 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman, CEO & President |
• • – |
2008-11-13 |
4 |
B |
$3.28 |
$164,035 |
D/D |
50,000 |
453,234 |
2.81 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman, CEO & President |
• • – |
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
403,234 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman, CEO & President |
• • – |
2007-08-20 |
4 |
B |
$7.45 |
$37,296 |
D/D |
5,000 |
203,234 |
2.81 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman, CEO & President |
• • – |
2007-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
198,234 |
0 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chairman, CEO & President |
• • – |
2006-03-07 |
4 |
B |
$6.81 |
$68,565 |
D/D |
10,000 |
98,234 |
2.81 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2005-06-10 |
4 |
B |
$5.75 |
$57,500 |
D/D |
10,000 |
88,234 |
2.81 |
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2004-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,000 |
|
- |
|
| ENZN |
Enzon Pharmaceuticals In... |
Director |
– • – |
2004-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,234 |
3,234 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
